Literature DB >> 8912885

Altered kinetics of CD4+ T cell proliferation and interferon-gamma production in the absence of CD8+ T lymphocytes in virus-infected beta2-microglobulin-deficient mice.

A Vikingsson1, K Pederson, D Muller.   

Abstract

CD8+ T cells are the major mediators of cytotoxic T cell activity controlling viral infections in normal mice. CD8+ T cells have also been implicated in regulating the activity of other immune cells. We have examined the possible regulatory role of CD8+ T cells on CD4+ T cells by comparing immune responses in mice expressing normal CD8+ T cell responses and in CD8+ T cell-deficient beta2-microglobulin "knockout" mice. In normal mice, infection with lymphocytic choriomeningitis virus (LCMV) results in a biphasic T cell immune response. First, CD8+ T cells proliferate and produce interferon-gamma (IFN-gamma), and then 2 to 4 days later CD4+ T cells proliferate and produce IFN-gamma. CD8+ T cell activity is not detected during LCMV infection in beta2-microglobulin-deficient mice. However, in beta2-microglobulin-deficient mice the CD4+ T cell expansion is exaggerated and occurs 2 days earlier than observed in normal mice. Furthermore, the CD4+ T cells have substantial cytotoxic activity, which is not observed in the CD4+ T cell population in normal mice. However, CD4+ T cell IFN-gamma production in beta2-microglobulin-deficient mice lags behind the proliferative response, resulting in a relative delay in overall T cell IFN-gamma production compared to normal mice. Taken together, these data suggest that CD8+ T cell activation peaks at an earlier time point than CD4+ T cell activation during the primary immune response to LCMV and that CD8+ T cells may inhibit CD4+ T cell proliferation and the development of CD4+ T cell cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912885     DOI: 10.1006/cimm.1996.0276

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.

Authors:  Z Wang; J D Davies
Journal:  Int Immunopharmacol       Date:  2006-11-28       Impact factor: 4.932

2.  Longitudinal proteomics analysis in the immediate microenvironment of islet allografts during progression of rejection.

Authors:  Oscar Alcazar; Luis F Hernandez; Ernesto S Nakayasu; Paul D Piehowski; Charles Ansong; Midhat H Abdulreda; Peter Buchwald
Journal:  J Proteomics       Date:  2020-05-20       Impact factor: 4.044

3.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 5.  Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.

Authors:  Christos P Argyropoulos; Shan Shan Chen; Yue-Harn Ng; Maria-Eleni Roumelioti; Kamran Shaffi; Pooja P Singh; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2017-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.